Ignite Creation Date:
2025-12-25 @ 2:42 AM
Ignite Modification Date:
2026-01-22 @ 8:26 AM
Study NCT ID:
NCT02205333
Status:
TERMINATED
Last Update Posted:
2017-06-28
First Post:
2014-07-18
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase 1b/2 Safety and Tolerability Study of MEDI6469 in Combination With Therapeutic Immune Agents or Monoclonal Antibodies
Sponsor:
MedImmune LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-08-13
Start Date Type:
ACTUAL
Primary Completion Date:
2016-04-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-04-08
Completion Date Type:
ACTUAL
First Submit Date:
2014-07-18
First Submit QC Date:
None
Study First Post Date:
2014-07-31
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-03-27
Results First Submit QC Date:
None
Results First Post Date:
2017-05-08
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-06-01
Last Update Post Date:
2017-06-28
Last Update Post Date Type:
ACTUAL